These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36539249)

  • 1. [Comparative Safety Study of Original and Generic Docetaxel without Alcohol in the Treatment of Breast Cancer].
    Hara M; Eto T; Ijichi H; Nakamura Y; Koga C; Tajiri W; Okamoto M; Tokunaga E; Misumi N
    Gan To Kagaku Ryoho; 2022 Dec; 49(12):1355-1359. PubMed ID: 36539249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of serious adverse events between the original and a generic docetaxel in breast cancer patients.
    Poirier E; Desbiens C; Poirier B; Hogue JC; Lemieux J; Doyle C; Leblond AF; Côté I; Cantin G; Provencher L
    Ann Pharmacother; 2014 Apr; 48(4):447-55. PubMed ID: 24321851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial.
    Shimozuma K; Ohashi Y; Takeuchi A; Aranishi T; Morita S; Kuroi K; Ohsumi S; Makino H; Katsumata N; Kuranami M; Suemasu K; Watanabe T; Hausheer FH
    Support Care Cancer; 2012 Dec; 20(12):3355-64. PubMed ID: 22584733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of adverse events following injection of original or generic docetaxel for the treatment of breast cancer.
    Tagawa N; Sugiyama E; Tajima M; Sasaki Y; Nakamura S; Okuyama H; Shimizu H; Sato VH; Sasaki T; Sato H
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):841-849. PubMed ID: 28864856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Perioperative Docetaxel-induced Limb Edema on Health-related Quality of Life in Patients with Early-stage Breast Cancer: A Prospective Observational Study.
    Matsumoto K; Morimoto Y; Wakatsuki J; Sakuma D; Mukouyama K; Inoue M; Kimura A; Hirosawa I; Watanabe K
    Yakugaku Zasshi; 2024; 144(6):685-690. PubMed ID: 38825477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema.
    Lim HK; Kim KM; Jeong SY; Choi EK; Jung J
    Integr Cancer Ther; 2017 Dec; 16(4):496-504. PubMed ID: 27151585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Evaluation of the Efficacy of Compression Therapy Using Sleeves and Stockings to Prevent Docetaxel-induced Peripheral Neuropathy in Breast Cancer Patients.
    Yamanouchi K; Kuba S; Matsumoto M; Yano H; Morita M; Sakimura C; Otsubo R; Hidaka M; Nagayasu T; Eguchi S
    Acta Med Okayama; 2022 Dec; 76(6):689-694. PubMed ID: 36549771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of oral dexamethasone given 24 hours previously on docetaxel-induced edema: a retrospective study].
    Kato A; Masuda N; Makihara K; Ueno H; Hirohata K; Yamauchi K; Yasojima H; Mizutani M; Yamamura J; Komori K
    Gan To Kagaku Ryoho; 2014 Feb; 41(2):211-4. PubMed ID: 24743199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A lower dose of docetaxel at 60 mg/m(2) could be continued longer for controlling peripheral edema in patients with metastatic breast cancer.
    Hosonaga M; Ito Y; Tokudome N; Takahashi S; Iwase T; Hatake K
    Breast Cancer; 2012 Oct; 19(4):329-34. PubMed ID: 21863309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the Incidence of Febrile Neutropenia Resulting in Hospital Admission Between the Branded Docetaxel and the Generic Formulations.
    Faqeer NA; Mashni O; Dawoud R; Rumman A; Hanoun E; Nazer L
    J Clin Pharmacol; 2017 Feb; 57(2):275-279. PubMed ID: 27479828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of the effect of docetaxel-induced edema on quality of life in patients with breast cancer and related factors: a prospective cohort study.
    Izawa T; Kobayashi A; Kawashima M; Kawaguchi-Sakita N; Nakakura A; Kataoka Y; Shide K; Mori Y; Yamazaki K; Toi M; Arao H
    BMC Womens Health; 2024 Mar; 24(1):165. PubMed ID: 38454375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observational study of clinical toxicity with different formulations of docetaxel in breast cancer patients.
    González-Haba-Peña E; Garrido-Siles M; Martínez-Bautista MJ; Burgos-San José A; Aldaz-Pastor A; Mangues-Bafalluy I
    Farm Hosp; 2020 Aug; 44(5):192-197. PubMed ID: 32853124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factors Contributing to the Occurrence of Edema in Breast Cancer Patients Receiving DTX Treatment].
    Uno K; Takada S; Hashishita H; Endo M
    Gan To Kagaku Ryoho; 2020 Jul; 47(7):1069-1073. PubMed ID: 32668854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of an AC-taxane versus AC-free regimen and paclitaxel versus docetaxel in patients with lymph node-positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial, a randomized comparative phase 3 study.
    Watanabe T; Kuranami M; Inoue K; Masuda N; Aogi K; Ohno S; Iwata H; Mukai H; Uemura Y; Ohashi Y
    Cancer; 2017 Mar; 123(5):759-768. PubMed ID: 28081304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective study of docetaxel or paclitaxel in patients with advanced or recurrent esophageal squamous cell carcinoma who previously received fluoropyrimidine- and platinum-based chemotherapy.
    Shirakawa T; Kato K; Nagashima K; Nishikawa A; Sawada R; Takahashi N; Shoji H; Sasaki Y; Honma Y; Iwasa S; Takashima A; Okita N; Hamaguchi T; Yamada Y; Shimada Y
    Cancer Chemother Pharmacol; 2014 Dec; 74(6):1207-15. PubMed ID: 25267597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer.
    Zaheed M; Wilcken N; Willson ML; O'Connell DL; Goodwin A
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012873. PubMed ID: 30776132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of lipid emulsions of docetaxel-linoleic acid conjugate in breast cancer.
    Zhang T; Li M; Yang R; Zhang D; Guan J; Yu J; Yang B; Zhang H; Zhang S; Liu D; Wang Y
    Int J Pharm; 2018 Jul; 546(1-2):61-69. PubMed ID: 29763687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose escalation study of epirubicin and docetaxel in patients with advanced or recurrent breast cancer.
    Ichinose I; Hamada Y; Mitsuyama S; Ishikawa E; Ikeda T; Kobayashi S; Horikoshi N; Tamura K
    Chemotherapy; 2008; 54(5):379-85. PubMed ID: 18758179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial.
    Hurvitz SA; Martin M; Symmans WF; Jung KH; Huang CS; Thompson AM; Harbeck N; Valero V; Stroyakovskiy D; Wildiers H; Campone M; Boileau JF; Beckmann MW; Afenjar K; Fresco R; Helms HJ; Xu J; Lin YG; Sparano J; Slamon D
    Lancet Oncol; 2018 Jan; 19(1):115-126. PubMed ID: 29175149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
    Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
    Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.